Back

Metabolomics Ex/GWAS in the Amish reveals novel insights into cardiometabolic disease pathways

Jallow, M. W.; Tzoneva, G.; Ye, B.; Backman, J.; Zavala, V. A.; Sosina, O.; Kapoor, M.; Verweij, N.; Landheer, K.; Geraghty, B.; Marchini, J.; Locke, A.; Bovijn, J.; Nielsen, J.; Lotta, L.; Regeneron Genetics Center, ; Montasser, M. E.; Lewis, J.; Mitchell, B. D.; Shuldiner, A. R.

2025-08-06 genomics
10.1101/2025.08.04.667775 bioRxiv
Show abstract

We conducted an exome and genome-wide association study (Ex/GWAS) of 1,015 metabolites in serum samples from 5,981 Amish adults. We identified 149 functional or likely functional genetic variants, based on CADD scores significantly associated (P < 5.8 x 10-8) with 519 metabolite levels, 69 of which were >10-fold enriched in the Amish versus Europeans in gnomAD. We discovered novel associations involving a PCK2 splice-donor variant (rs138881435) and metabolites important for energy metabolism and mitochondrial function. In UK Biobank participants, this variant was associated with increased longitudinal relaxation time (T1) values on liver MRI suggesting increased inflammation and fibrosis. Furthermore, we found novel associations involving ENPEP stop-gain variant (rs33966350) and peptide and amino acid metabolite levels, implicating ENPEPs roles in blood pressure regulation. Additional known and novel genetic variant-metabolite associations were identified including genes involved in Amish-enriched Mendelian diseases and cardiometabolic traits, providing insights into underlying mechanisms of these disorders.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.